Swietenia mahagony extract shows agonistic activity to PPARγ and gives ameliorative effects on diabetic db/db mice

Acta Pharmacologica Sinica

Volumn 26, Issue 2, 2005, Pages 220-222

  Li, Dan Dan ^a,b   Chen, Jun Hua ^a,d   Chen, Qing ^a,d   Li, Guo Wei ^a,d   Chen, Jing ^a,d   Yue, Jian Min ^a,d   Chen, Min Li ^c   Wang, Xiao Ping ^b   Shen, Jian Hua ^a,d   Shen, Xu ^a,d   Jiang, Hua Liang ^a,d  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b TONGJI UNIVERSITY   (China)

^c Zhejiang Traditional Chinese Medicine University   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Diabetes mellitus; Peroxisome proliferator activated receptor ; Swietenia mahagony; Yeast two hybrid

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; ROSIGLITAZONE; SWIETENIA MAHOGANY EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; GLUCOSE BLOOD LEVEL; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; SWIETENIA MAHOGANY; TWO HYBRID SYSTEM;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUGS, CHINESE HERBAL; MALE; MELIACEAE; MICE; PLANTS, MEDICINAL; PPAR GAMMA; SEEDS;

EID: 13444261343     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00527.x     Document Type: Article

References (13)

1. Willson TM, Brown PJ, Sternbach DD, Henke BR. The PPARs: from orphan receptors to drug discovery. J Med Chem 2000; 43: 527-50.
2. Kerstern S, Desverge B, Wahli W. Roles of PPARs in health and disease. Nature 2000; 405: 421-4.
3. Escher P, Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutation Res 2000; 448: 121-38.
4. Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet 1999; 354: 141-8.
5. Reginato MJ, Lazar MA. Mechanisms by which thiazolidinediones enhance insulin action. Trends Endoc Metab 1999; 10: 9-13.
6. Hulin B, McCarthy PA, Gibbs EM. The glitazone family of antidiabetic agents. Curr Pharm Des 1996; 2: 85-102.
7. Barry GS, William JH. Recent advances in peroxisome proliferator- activated receptor science. Curr Med Chem 2003; 10: 267-80.
8. Murphy GJ, Holder JC. PPARγ agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharm Sci 2000; 21: 469-74.
9. Shen JH, Xu XY, Cheng F, Liu H, Luo XM, Shen JK, et al. Virtual screening on natural products for discovering active compounds and target information. Curr Med Chem 2003; 10: 2327-42.
10. Yeast protocols handbook. Available from: http://www. bdbiosciences.com/clontech/techinfo/manuals/PDF/PT3024-1.pdf.
11. Chen Q, Chen J, Sun T, Shen JH, Shen X, Jiang HL. A yeast two-hybrid technology based system for the discovery of PPARγ agonist and antagonist. Anal Biochem 2004;335:253-9.
12. Taniguchi T, Mizukami J, inventors. Method for identifying or screening agonist and antagonist to PPAR. US patent 6 365 361. 2002 Aug 23.
13. Kadota S, Marpaaung L, Kikuchi T, Ekimoto H. Constituents of the seeds of Swietenia mahagoni JACQ. III. Structures of mahonin and secomahoganin. Chem Pharm Bull 1990; 38: 1495-500.